Aspire Ventures Precision Medicine
Pre-seed → Seed
Their stated focus (public profile)
Aspire Ventures Precision Medicine Fund (AVP) is an impact fund co-managed with Penn Medicine Lancaster General Health, focused on fast-tracking precision medicine technologies that leverage AI and IoT to deliver affordable, individualized healthcare solutions at scale. The fund supports early-stage ventures through an end-to-end ecosystem covering ideation, clinical trials, FDA approval, market adoption, and insurance reimbursement. AVP uses proprietary technology (the A2I adaptive AI platform) and in-house accelerators to reduce the time and capital needed to bring precision medicine innovations to market.
Stages: Pre-seed → Seed
Sectors: Healthtech, Life sciences, AI / ML, IoT, Cybersecurity
On file: 6 companies on record
Website: aspirevc.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.